Extended Data
SIDE EFFECTS
Bar chart showing, at baseline, how patients ranked the importance of 5 particular attributes when considering a glucose lowering treatment. Data presented as proportions of patients choosing each level of importance for each of the 5 attributes.Distribution of side effects experienced on each of the three study drugs (pioglitazone represented by blue bars, sitagliptin by yellow bars, and canagliflozin by red bars) with proportions experiencing the side effects at baseline shown by black bars.a) HbA1cs and b) Side effects on the three drugs, split by preferred therapy on 1